DJ-1 modulates aggregation and pathogenesis in models of huntington's disease

38Citations
Citations of this article
80Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The oxidation-sensitive chaperone protein DJ-1 has been implicated in several human disorders including cancer and neurodegenerative diseases. During neurodegeneration associated with protein misfolding, such as that observed in Alzheimer's disease and Huntington's disease (HD), both oxidative stress and protein chaperones have been shown to modulate disease pathways. Therefore, we set out to investigate whether DJ-1 plays a role in HD. We found that DJ-1 expression and its oxidation state are abnormally increased in the humanHDbrain, as well as in mouse and cell models of HD. Furthermore, overexpression of DJ-1 conferred protection in vivo against neurodegeneration in yeast and Drosophila. Importantly, the DJ-1 protein directly interacted with an expanded fragment of huntingtin Exon 1 (httEx1) in test tube experiments and in cell models and accelerated polyglutamine aggregation and toxicity in an oxidation-sensitive manner. Our findings clearly establish DJ-1 as a potential therapeutic target for HD and provide the basis for further studies into the role of DJ-1 in protein misfolding diseases. © The Author 2013. Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

Sajjad, M. U., Green, E. W., Miller-Fleming, L., Hands, S., Herrera, F., Campesan, S., … Wyttenbach, A. (2014). DJ-1 modulates aggregation and pathogenesis in models of huntington’s disease. Human Molecular Genetics, 23(3), 755–766. https://doi.org/10.1093/hmg/ddt466

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free